Trial Design Articles

Exploring the Future of Clinical Research for Immune-Mediated Inflammatory Diseases

Mar 27, 2017

By Ian Braithwaite, Eteri Tsetskhladze, MD, PhD

In the search for more effective treatments and cures, there are challenges that sponsors and CROs must confront when conducting IMID clinical trials.

Developing New Clinical Endpoints for Immuno-Oncology Studies

Feb 23, 2017

By Chris Smyth, PhD

Drug developers are using surrogate endpoints to monitor the effectiveness of immunotherapies, taking into account the differences between immunotherapy and traditional treatments.

Building Blocks for Better Balance

Sep 28, 2016

By Scott Hamilton, PhD, Carol Shum

While block randomization has been shown to be a more frequently used form of trial randomization design, the use of dynamic randomization has been shown to have optimal treatment group balancing results.

FAQs for Immunotherapy Trials

Sep 12, 2016

By Andrew Zupnick, PhD

Immunotherapy drugs have led to successes in the oncology space as the list of cancer survivors continues to grow. However, more work must be done to ensure that all patients who can benefit from these life-saving drugs receive them.

Future Directions of Cancer Immunotherapy in Clinical Trials

Jun 20, 2016

By Joseph Pierro, MD, Donald Cooper

Progress and innovation within oncology has accelerated to a paradigm that includes immunotherapy and bio-genomics. Collaborative approaches in the future will continue to transform treatments in hopes of improving patient quality of life.

Trial Design News

ERT Introduces Respiratory Solution

ERT has introduced a respiratory clinical trial solution to capture, measure and analyze Lung Clearance Index data.

SGS Announces Results of H3N2 Influenza Trial

SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers.

Almac Diagnostics, EORTC Collaborate for Tumor Profiling

Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples.

PPD Collaborates with Frenova

PPD has entered into a collaboration with drug and medical device contract clinical development services provider Frenova Renal Research.

native1_300x100
lorem ipsum